Pronóstico del mercado europeo de tratamiento de sarcopenia hasta 2030 – Análisis regional – por tipo de tratamiento (suplemento de vitamina D y calcio, suplemento de proteína, suplemento de vitamina B12 y otros) y canal de distribución (farmacias, canales minoristas, canales en línea y otros)
El aumento de la desnutrición y la deficiencia de vitaminas entre los adultos impulsa el mercado europeo del tratamiento de la sarcopenia
La desnutrición es uno de los principales factores de riesgo de la sarcopenia . Según la OMS, aproximadamente 2.300 millones de adultos en todo el mundo estaban desnutridos en 2021, lo que representa casi el 30% de la población mundial. Entre los factores de riesgo reportados, la deficiencia proteico-energética es una causa frecuente de sarcopenia. Además, la deficiencia o insuficiencia de vitamina D se asocia positivamente con un mayor riesgo de múltiples enfermedades, como cáncer, obesidad, enfermedades cardiovasculares y sarcopenia. Según los Institutos Nacionales de Salud (NIH), casi el 50% de la población mundial sufre de insuficiencia de vitamina D, y aproximadamente mil millones de personas tienen deficiencia de vitamina D.
Descripción general del mercado europeo del tratamiento de la sarcopenia
El mercado europeo del tratamiento de la sarcopenia está segmentado en Alemania, Francia, el Reino Unido, Italia, España y el resto de Europa. Europa ocupa una posición significativa en el mercado mundial del tratamiento de la sarcopenia y se estima que registrará una CAGR notable durante el período previsto.
Alemania es un mercado atractivo debido a su enfoque innovador hacia la atención sanitaria. Según la Oficina Federal de Estadística, el gasto sanitario en este país ascendió a 474 mil millones de dólares en 2021. La conciencia sobre la sarcopenia y la obesidad sarcopénica (OS) está aumentando gradualmente en las sociedades que envejecen en toda Alemania. La sarcopenia y el SO son comparativamente poco frecuentes (<5%) entre los hombres alemanes de 70 años o más. Por lo tanto, el aumento de los casos de trastornos ortopédicos, junto con la creciente demanda de suplementos nutricionales, impulsa el crecimiento del mercado del tratamiento de la sarcopenia en Alemania.
Ingresos del mercado europeo de tratamiento de sarcopenia y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado europeo de tratamiento de sarcopenia
El mercado europeo de tratamiento de sarcopenia se clasifica en tipo de tratamiento y canal de distribución y país.
Según el tipo de tratamiento, el mercado europeo de tratamiento de la sarcopenia se segmenta en suplementos de vitamina D y calcio, suplementos proteicos, suplementos de vitamina B12 y otros. El segmento de suplementos de vitamina D y calcio tuvo la mayor cuota de mercado de tratamiento de la sarcopenia en Europa en 2022.
En términos de canal de distribución, el mercado de tratamiento de la sarcopenia en Europa está segmentado en farmacias, canales minoristas, canales en línea y otros. El segmento de farmacias tuvo la mayor cuota de mercado de tratamiento de sarcopenia en Europa en 2022.
Por país, el mercado de tratamiento de sarcopenia en Europa está segmentado en Alemania, Francia, Italia, Reino Unido, España y el resto de Europa. Alemania dominó la cuota de mercado europea del tratamiento de la sarcopenia en 2022.
Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestlé Health Science SA, Novartis AG, Pfizer Inc y Sanofi SA son algunos de los Empresas líderes que operan en el mercado europeo del tratamiento de la sarcopenia.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.1 Europe Sarcopenia Treatment Market - Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market - Europe Market Analysis
5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
5.2 Europe Sarcopenia Treatment Market Forecast and Analysis
6. Europe Sarcopenia Treatment Market Analysis - By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe Sarcopenia Treatment Market Analysis - By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Europe Sarcopenia Treatment Market - Country Analysis
8.1 Europe
8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
Table 4. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
Table 5. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
Table 6. Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Country
Table 7. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 8. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 9. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 10. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 11. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 12. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 13. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 14. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 15. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 16. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 17. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Treatment Type
Table 18. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn) - By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market
List of Figures
Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
Figure 4. Europe Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Europe Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Germany Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 17. France Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 18. United Kingdom Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 19. Italy Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 20. Spain Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Europe Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market
1. Abbott Laboratories
2. Amway Corp
3. Bayer AG
4. GSK Plc
5. Metagenics LLC
6. Nestle Health Science SA
7. Novartis AG
8. Pfizer Inc
9. Sanofi SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sarcopenia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sarcopenia treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.